EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Navigating Treatment Decisions in Early-Stage Hormone Receptor–Positive Breast Cancer

Eitan Amir, Tyler Kristoff, Catherine Blaha, Uri Bender, Kevin Kalinsky, Erin Cobain

American Society of Clinical Oncology Educational Book · 2026-06 · 46 (3)

DOI: 10.1200/edbk-26-520488 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2026-06. Verfasst von Eitan Amir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Centre, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms, Receptors, Estrogen, Receptors, Progesterone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treating patients with early-stage hormone receptor–positive, human epidermal growth factor receptor 2–negative breast cancer is increasingly complex, driven by a growing array of therapeutic options, heterogeneous clinical benefit across patient subgroups, and the risk of treatment-related and financial toxicity. Major advances in tumor biology–guided care have improved risk stratification and helped identify patients most likely to benefit from chemotherapy, especially with the use of genomic assays. In this article, we examine key challenges and ongoing controversies in managing this breast cancer subtype, including the use of genomic assays in premenopausal women with node-positive disease, tailoring treatment in locally advanced tumors with favorable biology, and the current and emerging roles of circulating tumor DNA as a prognostic and predictive biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsReceptors, EstrogenReceptors, ProgesteroneHumansFemaleNeoplasm StagingBiomarkers, TumorErb-b2 Receptor Tyrosine KinasesPrognosisClinical Decision-MakingCirculating Tumor DNA

Substanzen

Biomarkers, TumorErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, ProgesteroneCirculating Tumor DNA

Autor:innen und Institutionen

  • Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Winship Cancer Institute at Emory University, Atlanta, GA.
  • University of Michigan, Ann Arbor, MI.

Zitieren

APA

Amir, E., Kristoff, T., Blaha, C., Bender, U., Kalinsky, K., & Cobain, E. (2026). Navigating Treatment Decisions in Early-Stage Hormone Receptor–Positive Breast Cancer. American Society of Clinical Oncology Educational Book, 46(3). https://doi.org/10.1200/edbk-26-520488

Vancouver

Amir E, Kristoff T, Blaha C, Bender U, Kalinsky K, Cobain E. Navigating Treatment Decisions in Early-Stage Hormone Receptor–Positive Breast Cancer. American Society of Clinical Oncology Educational Book. 2026;46(3). doi:10.1200/edbk-26-520488

BibTeX
@article{Amir2026,
  author = {Amir, Eitan and Kristoff, Tyler and Blaha, Catherine and Bender, Uri and Kalinsky, Kevin and Cobain, Erin},
  title = {Navigating Treatment Decisions in Early-Stage Hormone Receptor–Positive Breast Cancer},
  journal = {American Society of Clinical Oncology Educational Book},
  year = {2026},
  volume = {46},
  number = {3},
  doi = {10.1200/edbk-26-520488}
}
Kostenlos starten →